These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 2547072)

  • 1. Synthesis and antiviral activity of the enantiomeric forms of carba-5-iodo-2'-deoxyuridine and carba-(E)-5-(2-bromovinyl)-2'-deoxyuridine.
    Balzarini J; Baumgartner H; Bodenteich M; De Clercq E; Griengl H
    J Med Chem; 1989 Aug; 32(8):1861-5. PubMed ID: 2547072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbocyclic 5-iodo-2'-deoxyuridine (C-IDU) and carbocyclic (E)-5-(2-bromovinyl)-2'-deoxyuridine (C-BVDU) as unique examples of chiral molecules where the two enantiomeric forms are biologically active: interaction of the (+)- and (-)-enantiomers of C-IDU and C-BVDU with the thymidine kinase of herpes simplex virus type 1.
    Balzarini J; De Clercq E; Baumgartner H; Bodenteich M; Griengl H
    Mol Pharmacol; 1990 Mar; 37(3):395-401. PubMed ID: 2156153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and antiviral activity of the carbocyclic analogues of (E)-5-(2-halovinyl)-2'-deoxyuridines and (E)-5-(2-halovinyl)-2'-deoxycytidines.
    Herdewijn P; De Clercq E; Balzarini J; Vanderhaeghe H
    J Med Chem; 1985 May; 28(5):550-5. PubMed ID: 2985782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphonoformate and phosphonoacetate derivatives of 5-substituted 2'-deoxyuridines: synthesis and antiviral activity.
    Griengl H; Hayden W; Penn G; De Clercq E; Rosenwirth B
    J Med Chem; 1988 Sep; 31(9):1831-9. PubMed ID: 2842506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-(5-Bromothien-2-yl)-2'-deoxyuridine and 5-(5-chlorothien-2-yl)-2'-deoxyuridine are equipotent to (E)-5-(2-bromovinyl)-2'-deoxyuridine in the inhibition of herpes simplex virus type I replication.
    Wigerinck P; Pannecouque C; Snoeck R; Claes P; De Clercq E; Herdewijn P
    J Med Chem; 1991 Aug; 34(8):2383-9. PubMed ID: 1652017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highly selective cytostatic activity of (E)-5-(2-bromovinyl)-2'-deoxyuridine derivatives for murine mammary carcinoma (FM3A) cells transformed with the herpes simplex virus type 1 thymidine kinase gene.
    Balzarini J; De Clercq E; Verbruggen A; Ayusawa D; Seno T
    Mol Pharmacol; 1985 Dec; 28(6):581-7. PubMed ID: 3001499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological activity of 5-(2,2-difluorocyclopropyl)-2'-deoxyuridine deoxyuridine diastereomers.
    Tandon M; Singh S; Xu L; Kumar P; Wiebe LI; Knaus EE; Gati WP; Tempest ML
    Drug Des Discov; 1992; 9(1):79-91. PubMed ID: 1333829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thymidylate synthase is the principal target enzyme for the cytostatic activity of (E)-5-(2-bromovinyl)-2'-deoxyuridine against murine mammary carcinoma (FM3A) cells transformed with the herpes simplex virus type 1 or type 2 thymidine kinase gene.
    Balzarini J; De Clercq E; Verbruggen A; Ayusawa D; Shimizu K; Seno T
    Mol Pharmacol; 1987 Sep; 32(3):410-6. PubMed ID: 2823092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the thymidine kinase of a herpes simplex virus type 1 isolate that exhibits resistance to (E)-5-(2-bromovinyl)-2'-deoxyuridine.
    Wilber BA; Docherty JJ
    J Gen Virol; 1994 Jul; 75 ( Pt 7)():1743-7. PubMed ID: 8021603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereoelectronic properties of five anti-HSV-1 2'-deoxynucleosides analogues with heterocyclic substituents in the 5-position: a comparison with BVDU.
    Olivier A; Creuven I; Evrard C; Evrard G; Dory M; van Aerschot A; Wigerinck P; Herdewijn P; Durant F
    Antiviral Res; 1994 Aug; 24(4):289-304. PubMed ID: 7993074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and antiviral activity of (E)-5-(2-bromovinyl)uracil and (E)-5-(2-bromovinyl)uridine.
    De Clercq E; Desgranges C; Herdewijn P; Sim IS; Jones AS; McLean MJ; Walker RT
    J Med Chem; 1986 Feb; 29(2):213-7. PubMed ID: 3005566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and antiviral properties of 5-vinylpyrimidine nucleoside analogs.
    De Clercq E; Walker RT
    Pharmacol Ther; 1984; 26(1):1-44. PubMed ID: 6099893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Herpes simplex virus type 1 that exhibits herpes simplex virus type 2 sensitivity to (E)-5-(2-bromovinyl)-2'-deoxyuridine.
    Docherty JJ; Dobson AT; Trimble JJ; Jennings BA
    Intervirology; 1991; 32(5):308-15. PubMed ID: 1657822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and antiviral properties of (Z)-5-(2-bromovinyl)-2'-deoxyuridine.
    Jones AS; Rahim SG; Walker RT; De Clercq E
    J Med Chem; 1981 Jun; 24(6):759-60. PubMed ID: 6265638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Problems associated with the use of (E)-5-(2-bromovinyl)-2'-deoxyuridine for typing herpes simplex virus.
    Swierkosz EM; Arens MQ; Rivetna KA
    J Clin Microbiol; 1985 Mar; 21(3):459-61. PubMed ID: 2984249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of the diastereomers of 5-(2,2-dichlorocyclopropyl)- and 5-(2-chlorocyclopropyl)-2'-deoxyuridine, and the antiviral and cytotoxic activity of these and bromo analogues.
    Tandon M; Singh S; Wiebe LI; Knaus EE; Gati WP; Tempest ML
    Drug Des Deliv; 1991 Jul; 7(4):295-307. PubMed ID: 1657019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective antiherpetic activity of carbocyclic analogues of (E)-5-(2-halogenovinyl)-2'-deoxyuridines: dependence on specific phosphorylation by viral thymidine kinase.
    De Clercq E; Balzarini J; Bernaerts R; Herdewijn P; Verbruggen A
    Biochem Biophys Res Commun; 1985 Jan; 126(1):397-403. PubMed ID: 2982373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-Iodo-2'-deoxy-L-uridine and (E)-5-(2-bromovinyl)-2'-deoxy-L-uridine: selective phosphorylation by herpes simplex virus type 1 thymidine kinase, antiherpetic activity, and cytotoxicity studies.
    Spadari S; Ciarrocchi G; Focher F; Verri A; Maga G; Arcamone F; Iafrate E; Manzini S; Garbesi A; Tondelli L
    Mol Pharmacol; 1995 Jun; 47(6):1231-8. PubMed ID: 7603465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effects of (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU) and related compounds on herpes simplex virus (HSV)-infected cells and HSV thymidine kinase gene-transformed cells.
    Balzarini J; De Clercq E
    Methods Find Exp Clin Pharmacol; 1989 Jun; 11(6):379-89. PubMed ID: 2545982
    [No Abstract]   [Full Text] [Related]  

  • 20. Selection of L cell sublines resistant to (E)-5-(2-bromovinyl)-2'-deoxyuridine.
    Shiraki K; Vonka V; De Clercq E; Rapp F
    Intervirology; 1991; 32(4):228-33. PubMed ID: 1650764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.